Similar articles

• Sulindac: a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases.

  Brogden RN, Heel RC, Speight TM, Avery GS. Brogden RN, et al. Drugs. 1978 Aug;16(2):97-114. doi: 10.2165/00003495-197816020-00001. Drugs. 1978. PMID: 352667 Review. No abstract available.
• [Cooperative clinical study of Sulindac in arthrosis (hip joint and knee) in general medicine].

  Delcambre B. Delcambre B. Lille Med. 1977 Apr;22(4 Suppl 1):266-8. Lille Med. 1977. PMID: 327175 Clinical Trial. French. No abstract available.
• [Treatment of chronic polyarthritis with Sulindac].

  Vetter G, Picha B. Vetter G, et al. MMW Munch Med Wochenschr. 1977 Oct 21;119(42):1369-70. MMW Munch Med Wochenschr. 1977. PMID: 412071 Clinical Trial. German. No abstract available.
• Chemical and biological studies on indomethacin, sulindac and their analogs.

  Shen TY, Winter CA. Shen TY, et al. Adv Drug Res. 1977;12:90-245. Adv Drug Res. 1977. PMID: 343530 Review. No abstract available.
• Comparison of sulindac and aspirin in rheumatoid arthritis.

  Reynolds PM, Rhymer AR, MacLeod MM, Buchanan WW. Reynolds PM, et al. Curr Med Res Opin. 1977;4(7):485-91. doi: 10.1185/03007997709109337. Curr Med Res Opin. 1977. PMID: 321183 Clinical Trial.